We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

CNS
Poster (Digital)
Clinical
Patterns of relapse and clinical outcomes following stereotactic re-irradiation for glioblastoma
Susanne Rogers, Switzerland
PO-1108
Safety and efficacy of silibinin in patients with brain metastases after SRS: SUSTAIN trial
Ilaria Bonaparte, Italy
PO-1109
Radionecrosis in brain metastases, intact or cavities, treated with stereotactic radiotherapy
Sandra Fernandez Alonso, Spain
PO-1110
Robotic stereotactic radiotherapy for ≥10 brain metastases treated with single treatment planning.
Miriam Torrisi, Italy
PO-1111
Outcomes after Stereotactic Radiosurgery for Brain Metastases from Gastro-intestinal malignancies
Palak Sharma, Ireland
PO-1112
Financial toxicity, occupational status and QoL in meningioma patients treated with proton therapy
Milana Achtaewa, Austria
PO-1113
Brain directed therapy followed by systemic treatment in metastatic renal cell carcinoma
Maha Zarroug , United Kingdom
PO-1118
Mimicking neoadjuvant stereotactic radiosurgery for resection cavities of brain metastases
Carolin Senger, Germany
PO-1119
Radiation necrosis in patients treated with brain SRT: evaluation of clinical and dosimetric factors
Angela Barillaro, Italy
PO-1120
Simultaneous integrated boost with spot scanning proton beam irradiation for meningiomas
Carola Luetgendorf-Caucig, Austria
PO-1122
Fractionated stereotactic radiotherapy with volumetric modulated arc therapy for pituitary adenoma
Ana Castaño Cantos, Spain
PO-1123
Temozolomide followed by chemoradiotherapy versus upfront chemoradiotherapy in Glioblastoma
Azadeh Sharifian , Iran Islamic Republic of
PO-1124
Multifraction Stereotactic Radiosurgery as a safe therapy for limited brain metastasis
Victoria Vera Barragán, Spain
PO-1125
Stereotactic re-irradiation of relapsed intracranic lesions: a monoinstitutional experience
Chiara Chissotti, Italy
PO-1129
CSI or whole brain irradiation combined with HSCT for CNS recurrence of hematopoietic tumors.
Yuri Shimizu, Japan
PO-1132
Potential role of pre-radiotherapy MRI for target delineation in high-grade gliomas
Camilla Satragno, Italy
PO-1133
Reirradiation by stereotactic radiotherapy of brain metastases in case of local recurrence
François Lucia, France
PO-1136
Reirradiation versus systemic therapy for recurrent high-grade glioma: A systematic review
Ravi Marwah, Australia
PO-1137
Effectiveness and safety of Hypofractionated Stereotactic Radiotherapy in pituitary adenomas
Virginie Delgrange, France
PO-1139
VMAT based focused RT as an alternative to Stereotaxy in 1-3 brain mets in Oligometastatic Cancers
ANUPAM DATTA, India
PO-1140
adjuvant radiosurgery versus conformal radiation therapy for resected brain metastases
Sohan Shah, USA
PO-1141
Low TMT may be a negative predictive and prognostic marker in patients with GBM treated with CCRT
Kiril Zhelev, Bulgaria
PO-1142
Combining spinal LITT and SSRS for treatment of thoracic spinal metastases with epidural compression
Jing Li, USA
PO-1143
Radiosurgery and Regorafenib in recurrent high-grade gliomas: is it feasible?
Alba Fiorentino , Italy
PO-1144
Targeting Transgelin-2 by novel small molecule inhibitors to circumvent resistance in glioblastoma
Ashok Kumar, USA
PO-1145
Hypofractionated and Intensified Radiotherapy for nonsurgical Glioblastoma Multiforme
Íñigo Nieto Regueira, Spain
PO-1147
Transitioning from conventional photon therapy to proton therapy for primary brain tumors
Per Munck af Rosenschold, Sweden
PO-1148
Spinal ependymoma: Is treatment with proton therapy superior to photon therapy?
Shermaine Pan, United Kingdom
PO-1150
Initial and recurrent radiation-induced contrast enhancements following RT for brain metastases
Eva Meixner, Germany
PO-1152
Visual outcome after fractionated stereotactic radiotherapy for optic nerve sheath meningioma
Buket Kinaci-Tas, The Netherlands
PO-1153
Impact of dosimetric parameters on local control in stereotactic radiotherapy of brain metastases
Camille Berthet, France
PO-1154
Impact of radiation on immune cells in patients with low-grade brain tumor
Yoo Kyung Choi, Korea Republic of
PO-1156
Fractionated stereotactic radiotherapy as a primary therapy for cerebral arteriovenous malformation
JEONGSHIM LEE, Korea Republic of
PO-1157
Single-institution clinical experience using robust IMPT in skull base chordoma and chondrosarcoma
Vesna Miladinovic, The Netherlands
PO-1158
PROTON AND CARBON ION THERAPY FOR SKULL BASE CHORDOMA: 4-YEAR MONO-INSTITUTIONAL EXPERIENCE
Slavisa Tubin, Austria
PO-1159
Retrospective non-inferiority study of stereotactic radiosurgery for more than ten brain metastases.
Yutaro Koide, Japan
PO-1160